FAKTOR-OPTIONSSCHEIN - DR. HÖNLE Stock

Certificat

DE000MD221E6

Delayed Börse Stuttgart 08:31:20 2024-07-01 EDT
2.08 EUR -12.24% Intraday chart for FAKTOR-OPTIONSSCHEIN - DR. HÖNLE
Current month-19.66%
1 month-20.20%
Date Price Change
24-07-01 2.08 -12.24%
24-06-28 2.37 -15.05%
24-06-27 2.79 -3.46%
24-06-26 2.89 +0.35%
24-06-25 2.88 +0.35%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 08:31 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying DR. HÖNLE AG
Issuer Morgan Stanley
WKN MD221E
ISINDE000MD221E6
Date issued 2022-02-22
Strike 8.979
Maturity Unlimited
Parity 3.75 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 13.87
Lowest since issue 1.45

Company Profile

Dr Hoenle AG is a Germany-based company engaged in the basic materials and industrials sectors. The Company develops, manufactures and supplies ultraviolet (UV) equipment. The Company operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The Company is globally active, with over 69 locations in 27 countries.
Sector
-
More about the company

Ratings for Dr. Hönle AG

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Consensus: Dr. Hönle AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.95 EUR
Average target price
25.2 EUR
Spread / Average Target
+40.39%
Consensus